Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer

Oncotarget

Volumn 7, Issue 34, 2016, Pages 55222-55230

  Peng, Liu Sheng ^a   Mao, Fang Yuan ^a   Zhao, Yong Liang ^a   Wang, Ting Ting ^a   Chen, Na ^a   Zhang, Jin Yu ^a   Cheng, Ping ^a   Li, Wen Hua ^a   Lv, Yi Pin ^a   Teng, Yong Sheng ^a   Guo, Gang ^a   Luo, Ping ^a   Chen, Weisan ^b   Zou, Quan Ming ^a   Zhuang, Yuan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

Functional impairment; Gastric cancer; Immune escape; NKT like cells; Tumor progression

Indexed keywords

CD27 ANTIGEN; CD45RA ANTIGEN; CD69 ANTIGEN; DNAM 1 PROTEIN; GAMMA INTERFERON; GRANZYME B; KI 67 ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2D; TUMOR NECROSIS FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG; CD3 ANTIGEN; CD56 ANTIGEN; NCAM1 PROTEIN, HUMAN; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CD3+CD56+ NATURAL KILLER T LIKE CELL; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MEMORY T LYMPHOCYTE; NATURAL KILLER T CELL; PHENOTYPE; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; IMMUNOLOGY; STOMACH TUMOR; TUMOR ASSOCIATED LEUKOCYTE;

CD3 COMPLEX; CD56 ANTIGEN; HUMANS; LEUKOCYTE COMMON ANTIGENS; LYMPHOCYTES, TUMOR-INFILTRATING; NATURAL KILLER T-CELLS; PHENOTYPE; STOMACH NEOPLASMS; TUMOR MICROENVIRONMENT; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 7;

EID: 84983498976     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10484     Document Type: Article

References (30)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65: 87-108.
2. Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS, Lee BL, Kim WH. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer. 2008; 99: 1704-11.
3. Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, et al. Consensus nomenclature for CD8+ T cell phenotypes in cancer. Oncoimmunology. 2015; 4: e998538.
4. Zhuang Y, Peng LS, Zhao YL, Shi Y, Mao XH, Chen W, Pang KC, Liu XF, Liu T, Zhang JY, Zeng H, Liu KY, Guo G, et al. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology. 2012; 143: 951-62.e8.
5. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol. 2004; 4: 231-7.
6. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol. 2005; 23:877-900.
7. Golden-Mason L, Castelblanco N, O'Farrelly C, Rosen HR. Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection. J Virol. 2007; 81: 9292-8.
8. Lu PH, Negrin RS. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol. 1994; 153: 1687-96.
9. Kokordelis P, Krämer B, Boesecke C, Voigt E, Ingiliz P, Glässner A, Wolter F, Srassburg CP, Spengler U, Rockstroh JK, Nattermann J. CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C. J Acquir Immune Defic Syndr. 2015; 70: 338-46.
10. Pan K, Wang QJ, Liu Q, Zheng HX, Li YQ, Weng DS, Li JJ, Huang LX, He J, Chen SP, Ke ML, Zeng YX, Xia JC. The phenotype of ex vivo generated cytokine-induced killer cells is associated with overall survival in patients with cancer. Tumour Biol. 2014; 35: 701-7.
11. Bojarska-Junak A, Hus I, Sieklucka M, Wasik-Szczepanek E, Mazurkiewicz T, Polak P, Dmoszynska A, Rolinski J. Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome. Oncol Rep. 2010; 24: 803-10.
12. Wang H, Yang D, Xu W, Wang Y, Ruan Z, Zhao T, Han J, Wu Y. Tumor-derived soluble MICs impair CD3(+) CD56(+) NKT-like cell cytotoxicity in cancer patients. Immunol Lett. 2008; 120: 65-71.
13. Guo W, Xing C, Dong A, Lin X, Lin Y, Zhu B, He M, Yao R. Numbers and cytotoxicities of CD3+CD56+ T lymphocytes in peripheral blood of patients with acute myeloid leukemia and acute lymphocytic leukemia. Cancer Biol Ther. 2013; 14: 916-21.
14. Galon J, Angell HK, Bedognetti D, Marincola FM. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity. 2013; 39: 11-26.
15. Pagès F, Galon J, Dieu-Nosjean MC, Tartour E, Sautès-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010; 29: 1093-102.
16. Liu K, Yang K, Wu B, Chen H, Chen X, Chen X, Jiang L, Ye F, He D, Lu Z, Xue L, Zhang W, Li Q, et al. Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer. Medicine (Baltimore). 2015; 94: e1631.
17. Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS, Lee BL, Kim WH. prognostic implications of type and density of tumour infiltrating lymphocytes in gastric cancer. Br J Cancer. 2008; 99: 1704-11.
18. Norris S, Doherty DG, Collins C, McEntee G, Traynor O, Hegarty JE, O'Farrelly C. Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells. Hum Immunol. 1999; 60: 20-31.
19. Zumwalt TJ, Arnold M, Goel A, Boland CR. Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration. Oncotarget. 2015; 6: 2981-91. doi: 10.18632/oncotarget.3205.
20. Di Mitri D, Azevedo R, Henson SM, Libri V, Riddell NE, Macaulay R, Kipling D, Soares MV, Battistini L, Akbar AN. Reversible senescence in human CD4+CD45RA+CD27-memory T cells. J Immunol. 2011; 187: 2093-100.
21. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science. 2011; 331: 44-9.
22. Delobel P, Nugeyre MT, Cazabat M, Sandres-Sauné K, Pasquier C, Cuzin L, Marchou B, Massip P, Cheynier R, Barré-Sinoussi F, et al. Naïve T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy. J Virol. 2006; 80: 10229-36.
23. Jackson SE, Mason GM, Okecha G, Sissons JG, Wills MR. Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells. J Virol. 2014; 88: 10894-908.
24. Pievani A, Borleri G, Pende D, Moretta L, Rambaldi A, Golay J, Introna M. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity. Blood. 2011; 118: 3301-10.
25. Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015; 27: 450-61.
26. Johnston RJ, Comps-Agrar L, Hackney J, Yu X, Huseni M, Yang Y, Park S, Javinal V, Chiu H, Irving B, Eaton DL, Grogan JL. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell. 2014; 26: 923-37.
27. Benson DM Jr, Bakan CE, Mishra A, Hofmeister CC, Efebera Y, Becknell B, Baiocchi RA, Zhang J, Yu J, Smith MK, Greenfield CN, Porcu P, Devine SM, et al. The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. Blood. 2010; 116: 2286-94.
28. Thomas DA, Massagué J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell. 2005; 8: 369-80.
29. Wrzesinski SH, Wan YY, Flavell RA. Transforming growth factor-beta and the immune response: implications for anticancer therapy. Clin Cancer Res. 2007; 13: 5262-70.
30. Peng LS, Zhuang Y, Shi Y, Zhao YL, Wang TT, Chen N, Cheng P, Liu T, Liu XF, Zhang JY, Zuo QF, Mao XH, Guo G, et al. Increased tumor-infiltrating CD8(+)Foxp3 (+) T lymphocytes are associated with tumor progression in human gastric cancer. Cancer Immunol Immunother. 2012; 61: 2183-92.